ナルコレプシー治療薬市場のシェア・規模・動向・産業分析・予測 (2023年～2032年)：タイプ (カタプレキシー・カタプレキシーを伴わないナルコレプシー・二次性ナルコレプシー)・製品・地域別

世界のナルコレプシー治療薬の市場規模は、2032年には77億5,000万米ドルの規模に成長すると予測されています。

当レポートでは、世界のナルコレプシー治療薬の市場を調査し、市場概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のナルコレプシー治療薬市場の洞察

• 産業概要
• 市場力学
  • 推進要因と機会
  • 抑制要因と課題
• ポーターのファイブフォース分析
• PESTEL分析
• 産業動向
• バリューチェーン分析
• COVID-19：影響分析

第5章 世界のナルコレプシー治療薬市場：タイプ別

• 主な調査結果
• カタプレキシー
• カタプレキシーを伴わないナルコレプシー
• 二次性ナルコレプシー

第6章 世界のナルコレプシー治療薬市場：製品別

• 主な調査結果
• オキシベートナトリウム
• 中枢神経刺激薬
• SSRI (選択的セロトニン再取り込み阻害薬)
• 三環系抗うつ薬

第7章 世界のナルコレプシー治療薬市場：地域別

• 主な調査結果
• 北米
• 欧州
• アジア太平洋
• 中東およびアフリカ
• ラテンアメリカ

第8章 競合情勢

• 拡張・買収の分析
• 提携/協力/合意/展示会

第9章 企業プロファイル

• Addrenex Pharmaceuticals, Inc
• Arena Pharmaceuticals, Inc.
• BIOPROJET
• Cephalon, Inc
• Evotec AG
• Graymark Healthcare, Inc.
• Hypnion, Inc
• Jazz Pharmaceuticals, Inc
• Ligand Pharmaceuticals, Inc
• Teva Pharmaceutical Industries Ltd.

List of Tables

• Table 1 Global Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 2 Global Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 3 Narcolepsy Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)
• Table 4 North America: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 5 North America: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 6 U.S.: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 7 U.S.: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 8 Canada: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 9 Canada: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 10 Europe: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 11 Europe: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 12 UK: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 13 UK: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 14 France: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 15 France: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 16 Germany: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 17 Germany: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 18 Italy: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 19 Italy: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 20 Spain: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 21 Spain: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 22 Netherlands: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 23 Netherlands: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 24 Russia: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 25 Russia: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 26 Asia Pacific: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 27 Asia Pacific: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 28 China: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 29 China: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 30 India: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 31 India: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 32 Malaysia: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 33 Malaysia: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 34 Japan: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 35 Japan: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 36 Indonesia: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 37 Indonesia: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 38 South Korea: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 39 South Korea: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 40 Middle East & Africa: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 41 Middle East & Africa: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 42 Saudi Arabia: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 43 Saudi Arabia: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 44 UAE: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 45 UAE: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 46 Israel: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 47 Israel: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 48 South Africa: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 49 South Africa: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 50 Latin America: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 51 Latin America: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 52 Mexico: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 53 Mexico: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 54 Brazil: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 55 Brazil: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• Table 56 Argentina: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• Table 57 Argentina: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)

List of Figures

Figure 1 Global Narcolepsy Therapeutics Market, 2019-2032 (USD Billion)

Figure 2 Integrated Ecosystem

Figure 3 Research Methodology: Top-Down & Bottom-Up Approach

Figure 4 Market by Geography

Figure 5 Porter's Five Forces

Figure 6 Market by Product

Figure 7 Global Narcolepsy Therapeutics Market, by Product, 2022 & 2032 (USD Billion)

Figure 8 Market by Type

Figure 9 Global Narcolepsy Therapeutics Market, by Type, 2022 & 2032 (USD Billion)

Figure 10 Narcolepsy Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)

Figure 11 Strategic Analysis - Narcolepsy Therapeutics Market

The global narcolepsy therapeutics market size is expected to reach USD 7.75 billion by 2032, according to a new study by Polaris Market Research. The report "Narcolepsy Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Type (Cataplexy, Narcolepsy without Cataplexy, Secondary Narcolepsy); By Product; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Narcolepsy therapeutics market is driven by several factors, including increasing awareness and diagnosis of narcolepsy, the availability of effective treatments, and the development of new medications, drive market growth. Treatments for narcolepsy include stimulants to promote wakefulness, sodium oxybate to improve nighttime sleep and reduce cataplexy, and antidepressants to manage cataplexy and other symptoms.

Recent developments in the narcolepsy therapeutics market, such as the approval of new medications and formulations, the acquisition of existing drugs by companies, and the ongoing research and development of new treatments, are expected to drive market growth.

For example, the approval of Xywav (calcium, magnesium, potassium, and sodium oxybates) and Wakix (pitolisant) by the U.S. Food and Drug Administration (FDA) in 2020, and the acquisition of Sunosi (solriamfetol) by Axsome Therapeutics Inc. in 2021, are expected to increase the availability of effective treatments for narcolepsy.

The increasing use of telemedicine and digital health technologies to improve access to healthcare and support remote monitoring and management of patients with narcolepsy is expected to further drive market growth.

Narcolepsy Therapeutics Market Report Highlights:

cataplexy segment is expected to dominate the narcolepsy therapeutics market over the forecast period due to increase in the demand for cataplexy treatment and increased prevalence of the narcolepsy.

Sodium Oxybate segment held a largest market share and will continue the dominance over the forecast period, due to a most commonly prescribed medicine for the cataplexy treatment.

North America dominates the global market due to the prevalence of the narcolepsy is highest in this region and FDA has approved several medications for the treatment of narcolepsy.

The global key market players include Addrenex Pharmaceuticals, Cephalon, Inc., Arena Pharmaceuticals, Inc., Ligand Pharmaceuticals, Inc., BIOPROJET, Inc., Evotec AG, Graymark Healthcare, Inc., Hypnion, Inc., Jazz Pharmaceuticals, Inc., and Teva Pharmaceutical Industries Ltd.

Polaris Market Research has segmented the Narcolepsy Therapeutics market report based on type, product, and region:

Narcolepsy Therapeutics, Type Outlook (Revenue - USD Billion, 2019 - 2032)

Cataplexy

Narcolepsy without Cataplexy

Secondary Narcolepsy

Narcolepsy Therapeutics, Product Outlook (Revenue - USD Billion, 2019 - 2032)

Sodium Oxybate

Central Nervous System Stimulants

Selective Serotonin Reuptake Inhibitor

Tricyclic Antidepressants

Narcolepsy Therapeutics, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Narcolepsy Therapeutics Market Insights

• 4.1. Narcolepsy Therapeutics Market - Industry Snapshot
• 4.2. Narcolepsy Therapeutics Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Increasing global prevalence of narcolepsy
    • 4.2.1.2. Narcolepsy awareness programs and services
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Adverse effects and risks related to narcolepsy drugs
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTLE Analysis
• 4.5. Narcolepsy Therapeutics Industry trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Narcolepsy Therapeutics Market, by Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Narcolepsy Therapeutics, by Type, 2019-2032 (USD Billion)
• 5.3. Cataplexy
  • 5.3.1. Global Narcolepsy Therapeutics Market, by Cataplexy, by Region, 2019-2032 (USD Billion)
• 5.4. Narcolepsy without Cataplexy
  • 5.4.1. Global Narcolepsy Therapeutics Market, by Narcolepsy without Cataplexy, by Region, 2019-2032 (USD Billion)
• 5.5. Secondary Narcolepsy
  • 5.5.1. Global Narcolepsy Therapeutics Market, by Secondary Narcolepsy, by Region, 2019-2032 (USD Billion)

6. Global Narcolepsy Therapeutics Market, by Product

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
• 6.3. Sodium Oxybate
  • 6.3.1. Global Narcolepsy Therapeutics Market, by Sodium Oxybate, by Region, 2019-2032 (USD Billion)
• 6.4. Central Nervous System Stimulants
  • 6.4.1. Global Narcolepsy Therapeutics Market, by Central Nervous System Stimulants, by Region, 2019-2032 (USD Billion)
• 6.5. Selective Serotonin Reuptake Inhibitor
  • 6.5.1. Global Narcolepsy Therapeutics Market, by Selective Serotonin Reuptake Inhibitor, by Region, 2019-2032 (USD Billion)
• 6.6. Tricyclic Antidepressants
  • 6.6.1. Global Narcolepsy Therapeutics Market, by Tricyclic Antidepressants, by Region, 2019-2032 (USD Billion)

7. Global Narcolepsy Therapeutics Market, by Geography

• 7.1. Key findings
• 7.2. Introduction
  • 7.2.1. Narcolepsy Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)
• 7.3. Narcolepsy Therapeutics Market - North America
  • 7.3.1. North America: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • 7.3.2. North America: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 7.3.3. Narcolepsy Therapeutics Market - U.S.
    • 7.3.3.1. U.S.: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.3.3.2. U.S.: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 7.3.4. Narcolepsy Therapeutics Market - Canada
    • 7.3.4.1. Canada: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.3.4.2. Canada: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• 7.4. Narcolepsy Therapeutics Market - Europe
  • 7.4.1. Europe: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • 7.4.2. Europe: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 7.4.3. Narcolepsy Therapeutics Market - UK
    • 7.4.3.1. UK: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.4.3.2. UK: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 7.4.4. Narcolepsy Therapeutics Market - France
    • 7.4.4.1. France: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.4.4.2. France: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 7.4.5. Narcolepsy Therapeutics Market - Germany
    • 7.4.5.1. Germany: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.4.5.2. Germany: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 7.4.6. Narcolepsy Therapeutics Market - Italy
    • 7.4.6.1. Italy: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.4.6.2. Italy: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 7.4.7. Narcolepsy Therapeutics Market - Spain
    • 7.4.7.1. Spain: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.4.7.2. Spain: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 7.4.8. Narcolepsy Therapeutics Market - Netherlands
    • 7.4.8.1. Netherlands: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.4.8.2. Netherlands: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 7.4.9. Narcolepsy Therapeutics Market - Russia
    • 7.4.9.1. Russia: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.4.9.2. Russia: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• 7.5. Narcolepsy Therapeutics Market - Asia Pacific
  • 7.5.1. Asia Pacific: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • 7.5.2. Asia Pacific: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 7.5.3. Narcolepsy Therapeutics Market - China
    • 7.5.3.1. China: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.5.3.2. China: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 7.5.4. Narcolepsy Therapeutics Market - India
    • 7.5.4.1. India: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.5.4.2. India: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 7.5.5. Narcolepsy Therapeutics Market - Malaysia
    • 7.5.5.1. Malaysia: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.5.5.2. Malaysia: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 7.5.6. Narcolepsy Therapeutics Market - Japan
    • 7.5.6.1. Japan: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.5.6.2. Japan: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 7.5.7. Narcolepsy Therapeutics Market - Indonesia
    • 7.5.7.1. Indonesia: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.5.7.2. Indonesia: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 7.5.8. Narcolepsy Therapeutics Market - South Korea
    • 7.5.8.1. South Korea: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.5.8.2. South Korea: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• 7.6. Narcolepsy Therapeutics Market - Middle East & Africa
  • 7.6.1. Middle East & Africa: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • 7.6.2. Middle East & Africa: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 7.6.3. Narcolepsy Therapeutics Market - Saudi Arabia
    • 7.6.3.1. Saudi Arabia: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.6.3.2. Saudi Arabia: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 7.6.4. Narcolepsy Therapeutics Market - UAE
    • 7.6.4.1. UAE: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.6.4.2. UAE: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 7.6.5. Narcolepsy Therapeutics Market - Israel
    • 7.6.5.1. Israel: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.6.5.2. Israel: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 7.6.6. Narcolepsy Therapeutics Market - South Africa
    • 7.6.6.1. South Africa: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.6.6.2. South Africa: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
• 7.7. Narcolepsy Therapeutics Market - Latin America
  • 7.7.1. Latin America: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • 7.7.2. Latin America: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 7.7.3. Narcolepsy Therapeutics Market - Mexico
    • 7.7.3.1. Mexico: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.7.3.2. Mexico: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 7.7.4. Narcolepsy Therapeutics Market - Brazil
    • 7.7.4.1. Brazil: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.7.4.2. Brazil: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 7.7.5. Narcolepsy Therapeutics Market - Argentina
    • 7.7.5.1. Argentina: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.7.5.2. Argentina: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)

8. Competitive Landscape

• 8.1. Expansion and Acquisition Analysis
  • 8.1.1. Expansion
  • 8.1.2. Acquisitions
• 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

• 9.1. Addrenex Pharmaceuticals, Inc
  • 9.1.1. Company Overview
  • 9.1.2. Financial Performance
  • 9.1.3. Product Benchmarking
  • 9.1.4. Recent Development
• 9.2. Arena Pharmaceuticals, Inc.
  • 9.2.1. Company Overview
  • 9.2.2. Financial Performance
  • 9.2.3. Product Benchmarking
  • 9.2.4. Recent Development
• 9.3. BIOPROJET
  • 9.3.1. Company Overview
  • 9.3.2. Financial Performance
  • 9.3.3. Product Benchmarking
  • 9.3.4. Recent Development
• 9.4. Cephalon, Inc
  • 9.4.1. Company Overview
  • 9.4.2. Financial Performance
  • 9.4.3. Product Benchmarking
  • 9.4.4. Recent Development
• 9.5. Evotec AG
  • 9.5.1. Company Overview
  • 9.5.2. Financial Performance
  • 9.5.3. Product Benchmarking
  • 9.5.4. Recent Development
• 9.6. Graymark Healthcare, Inc.
  • 9.6.1. Company Overview
  • 9.6.2. Financial Performance
  • 9.6.3. Product Benchmarking
  • 9.6.4. Recent Development
• 9.7. Hypnion, Inc
  • 9.7.1. Company Overview
  • 9.7.2. Financial Performance
  • 9.7.3. Product Benchmarking
  • 9.7.4. Recent Development
• 9.8. Jazz Pharmaceuticals, Inc
  • 9.8.1. Company Overview
  • 9.8.2. Financial Performance
  • 9.8.3. Product Benchmarking
  • 9.8.4. Recent Development
• 9.9. Ligand Pharmaceuticals, Inc
  • 9.9.1. Company Overview
  • 9.9.2. Financial Performance
  • 9.9.3. Product Benchmarking
  • 9.9.4. Recent Development
• 9.10. Teva Pharmaceutical Industries Ltd.
  • 9.10.1. Company Overview
  • 9.10.2. Financial Performance
  • 9.10.3. Product Benchmarking
  • 9.10.4. Recent Development